Viewing Study NCT01697020


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-02-26 @ 3:15 AM
Study NCT ID: NCT01697020
Status: COMPLETED
Last Update Posted: 2013-12-02
First Post: 2012-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions
Sponsor: Nova Laboratories Limited
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia View
Keywords: